Skip to main content

Table 4 Treatment balancing properties of 1:2 sequence balance minimisation with 0 (treatment totals only) to 10 prognostic factors with 2 levels, treatment totals weighted as one, sample size 30, 60 and 120, p = 0.95 to 0.5

From: Sequence balance minimisation: minimising with unequal treatment allocations

Random element

 

Treatment totals only

Number of factors

1

2

3

4

5

6

7

8

9

10

Sample size (n = 30), the expected number of participants allocated to the treatment with smallest-allocation ratio (n = 10)

p = 0.5

Mean (SE)

10.9 (0.07)

10.8 (0.06)

10.5 (0.03)

10.2 (0.03)

10.1 (0.03)

10.1 (0.03)

10.1 (0.03)

10.0 (0.04)

10.1 (0.03)

10.0 (0.03)

10.1 (0.03)

 

Median (p1–p99)

11 (6–16)

11 (7–15)

10 (8–13)

10 (8–13)

10 (8–13)

10 (8–12)

10 (8–13)

10 (7–13)

10 (8–13)

10 (8–13)

10 (8–13)

p = 0.6

Mean (SE)

10.7 (0.06)

10.7 (0.05)

10.4 (0.03)

10.2 (0.03)

10.2 (0.03)

10.1 (0.03)

10.1 (0.03)

10.1 (0.03)

10.1 (0.03)

10.1 (0.03)

10.1 (0.03)

 

Median (p1–p99)

11 (7–15)

11 (7–15)

10 (8–13)

10 (8–13)

10 (8–13)

10 (8–13)

10 (8–13)

10 (7–12)

10 (8–12.5)

10 (8–13)

10 (8–13)

p = 0.7

Mean (SE)

10.5 (0.05)

10.5 (0.04)

10.3 (0.03)

10.2 (0.03)

10.1 (0.03)

10.1 (0.03)

10.1 (0.03)

10.1 (0.03)

10.1 (0.03)

10.1 (0.03)

10.1 (0.03)

 

Median (p1–p99)

10 (6–14)

10 (7–14)

10 (8–13)

10 (8–12.5)

10 (8–12.5)

10 (8–12)

10 (8–12)

10 (8–13)

10 (8–13)

10 (8–13)

10 (8–13)

p = 0.8

Mean (SE)

10.3 (0.04)

10.4 (0.03)

10.2 (0.03)

10.1 (0.03)

10.1 (0.03)

10.1 (0.03)

10.1 (0.03)

10.1 (0.03)

10.1 (0.03)

10.2 (0.03)

10.1 (0.04)

 

Median (p1–p99)

10 (7–14)

10 (8–13)

10 (8–13)

10 (8–12)

10 (8–13)

10 (8–12)

10 (8–12.5)

10 (8–12)

10 (8–13)

10 (8–13)

10 (7–13)

p = 0.85

Mean (SE)

10.3 (0.03)

10.3 (0.03)

10.2 (0.03)

10.1 (0.03)

10.1 (0.03)

10.1 (0.03)

10.0 (0.03)

10.0 (0.03)

10.1 (0.03)

10.1 (0.03)

10.0 (0.03)

 

Median (p1–p99)

10 (8–13)

10 (8–13)

10 (8–12)

10 (8–12)

10 (8–12)

10 (8–12)

10 (8–12.5)

10 (8–12)

10 (8–13)

10 (7.5–12.5)

10 (7–13)

p = 0.9

Mean (SE)

10.2 (0.03)

10.2 (0.03)

10.1 (0.03)

10.1 (0.03)

10.1 (0.03)

10.0 (0.03)

10.0 (0.03)

10.0 (0.03)

10.1 (0.03)

10.0 (0.04)

10.1 (0.03)

 

Median (p1–p99)

10 (8–12)

10 (8–13)

10 (8–12)

10 (8–12.5)

10 (8–12)

10 (8–12)

10 (8–12)

10 (8–12)

10 (7.5–13)

10 (7–13)

10 (8–12)

p = 0.95

Mean (SE)

10.1 (0.02)

10.1 (0.02)

10.0 (0.03)

10.1 (0.03)

10.1 (0.03)

10.0 (0.03)

10.1 (0.03)

10.1 (0.03)

10.1 (0.03)

10.1 (0.03)

10.1 (0.03)

 

Median (p1–p99)

10 (9–12)

10 (8–12)

10 (8–12)

10 (8–12)

10 (8–12)

10 (8–12)

10 (8–12)

10 (8–12)

10 (8–13)

10 (8–13)

10 (8–13)

Sample size (n = 60), the expected number of participants allocated to the treatment with smallest-allocation ratio (n = 20)

p = 0.5

Mean (SE)

21.7 (0.09)

21.4 (0.07)

20.9 (0.06)

20.6 (0.06)

20.4 (0.05)

20.3 (0.05)

20 (0.05)

20.1 (0.05)

20.1 (0.05)

20.1 (0.05)

20.1 (0.05)

 

Median (p1–p99)

22 (15–29)

21 (16–27)

21 (17–25)

21 (17–26)

20 (17–24)

20 (17–24)

20 (17–23)

20 (17–23.5)

20 (17–23.5)

20 (17–24)

20 (16.5–24)

p = 0.6

Mean (SE)

21.3 (0.09)

21.1 (0.07)

20.9 (0.06)

20.5 (0.05)

20.4 (0.04)

20.3 (0.05)

20.1 (0.04)

20.1 (0.05)

20.1 (0.05)

20.2 (0.05)

20.1 (0.05)

 

Median (p1–p99)

21 (16–28)

21 (16–27)

21 (17–26)

20 (17–24)

20 (17–24)

20 (17–23.5)

20 (17–24)

20 (17–24)

20 (17–23)

20 (17–24)

20 (17–24)

p = 0.7

Mean (SE)

20.9 (0.07)

21.0 (0.06)

20.7 (0.05)

20.4 (0.05)

20.4 (0.04)

20.2 (0.04)

20.1 (0.04)

20.1 (0.05)

20.0 (0.05)

20.1 (0.05)

20.2 (0.05)

 

Median (p1–p99)

21 (16–26)

21 (17–26)

21 (17–25)

20 (17–24)

20 (17–24)

20 (17–23)

20 (17–24)

20 (17–23)

20 (17–23)

20 (17–24)

20 (17–24)

p = 0.8

Mean (SE)

20.8 (0.06)

20.6 (0.05)

20.4 (0.04)

20.3 (0.05)

20.2 (0.04)

20.2 (0.04)

20.1 (0.04)

20.0 (0.04)

20.0 (0.05)

20.1 (0.05)

20.1 (0.05)

 

Median (p1–p99)

21 (17–25)

21 (17–24)

20 (17–24)

20 (17–24)

20 (17–23)

20 (17–24)

20 (17–23)

20 (17–23)

20 (17–24)

20 (17–24)

20 (17–24)

p = 0.85

Mean (SE)

20.5 (0.05)

20.5 (0.04)

20.3 (0.04)

20.2 (0.04)

20.2 (0.04)

20.1 (0.04)

20.1 (0.05)

20.1 (0.04)

20.1 (0.05)

20.1 (0.05)

20.2 (0.05)

 

Median (p1–p99)

21 (17–24)

20 (18–24)

20 (17–23)

20 (17–24)

20 (17–23)

20 (17–23)

20 (17–23)

20 (17–23)

20 (17–24)

20 (17–24)

20 (17–24)

p = 0.9

Mean (SE)

20.4 (0.04)

20.3 (0.04)

20.1 (0.04)

20.2 (0.04)

20.2 (0.04)

20.1 (0.04)

20.1 (0.04)

20.1 (0.05)

20.2 (0.05)

20.1 (0.05)

20.1 (0.05)

 

Median (p1–p99)

20 (17–24)

20 (17–23.5)

20 (17–23)

20 (17–23.5)

20 (17–23)

20 (17–23)

20 (17–23)

20 (17–24)

20 (17–24)

20 (17–24)

20 (16–24)

p = 0.95

Mean (SE)

20.2 (0.03)

20.2 (0.03)

20.1 (0.04)

20.1 (0.04)

20.1 (0.04)

20.2 (0.04)

20.1 (0.04)

20.1 (0.04)

20.2 (0.05)

20.1 (0.05)

20.1 (0.05)

 

Median (p1–p99)

20 (18–23)

20 (18–23)

20 (17–23)

20 (17–23)

20 (17–23)

20 (17–23.5)

20 (16.5–23)

20 (17–23)

20 (17–24)

20 (16.5–24)

20 (17–24)

Sample size (n = 120), the expected number of participants allocated to the treatment with smallest-allocation ratio (n = 40)

p = 0.5

Mean (SE)

43.4 (0.14)

42.7 (0.09)

41.2 (0.08)

40.8 (0.07)

40.5 (0.07)

40.2 (0.07)

40.3 (0.07)

40.1 (0.07)

40.3 (0.07)

40.2 (0.07)

40.3 (0.07)

 

Median (p1–p99)

43 (33–54)

43 (36–49.5)

41 (36–47)

41 (36–46)

40 (36–45)

40 (35–46)

40 (35–45)

40 (35–45.5)

40 (35–45)

40 (35–46)

40 (36–45)

p = 0.6

Mean (SE)

42.5 (0.12)

42.1 (0.09)

41.1 (0.07)

40.7 (0.07)

40.3 (0.07)

40.2 (0.07)

40.3 (0.07)

40.2 (0.07)

40.2 (0.07)

40.3 (0.07)

40.4 (0.07)

 

Median (p1–p99)

42 (34–51.5)

42 (36–49)

41 (36–46)

41 (36–46)

40 (36–45)

40 (35–45)

40 (35–45)

40 (35–45)

40 (35–45)

40 (35–46)

40 (36–45)

p = 0.7

Mean (SE)

42.0 (0.10)

41.6 (0.08)

40.8 (0.07)

40.6 (0.07)

40.2 (0.07)

40.3 (0.07)

40.2 (0.07)

40.3 (0.07)

40.2 (0.07)

40.2 (0.07)

40.2 (0.07)

 

Median (p1–p99)

42 (35–49)

42 (36–47.5)

41 (36–46)

41 (36–45)

40 (35–45)

40 (36–45)

40 (35–45)

40 (35.5–45)

40 (35–45)

40 (35–45)

40 (36–45)

p = 0.8

Mean (SE)

41.3 (0.08)

41.1 (0.07)

40.6 (0.06)

40.4 (0.06)

40.3 (0.06)

40.1 (0.07)

40.2 (0.06)

40.2 (0.07)

40.2 (0.07)

40.2 (0.07)

40.3 (0.07)

 

Median (p1–p99)

41 (36–47)

41 (36–46)

41 (36–45)

40 (36–45)

40 (35.5–45)

40 (35–45)

40 (36–45)

40 (35–45)

40 (35–45)

40 (35.5–45)

40 (36–45)

p = 0.85

Mean (SE)

41.0 (0.07)

40.8 (0.06)

40.5 (0.06)

40.4 (0.06)

40.3 (0.07)

40.3 (0.07)

40.2 (0.07)

40.4 (0.07)

40.2 (0.07)

40.3 (0.07)

40.2 (0.07)

 

Median (p1–p99)

41 (36–46)

41 (37–45)

40 (36–45)

40 (36–45)

40 (36–45)

40 (35–45)

40 (35–45)

40 (35–46)

40 (35–45)

40 (35–45)

40 (35–45)

p = 0.9

Mean (SE)

40.7 (0.06)

40.5 (0.06)

40.2 (0.06)

40.2 (0.06)

40.2 (0.06)

40.1 (0.06)

40.2 (0.07)

40.2 (0.07)

40.2 (0.07)

40.2 (0.07)

40.2 (0.07)

 

Median (p1–p99)

41 (36–45)

40 (36–45)

40 (35–45)

40 (36–44)

40 (35–45)

40 (36–45)

40 (36–45.5)

40 (36–45)

40 (35–46)

40 (35–45.5)

40 (35–45.5)

p = 0.95

Mean (SE)

40.4 (0.04)

40.3 (0.05)

40.1 (0.06)

40.2 (0.06)

40.1 (0.06)

40.2 (0.07)

40.3 (0.06)

40.1 (0.07)

40.3 (0.07)

40.2 (0.07)

40.3 (0.07)

 

Median (p1–p99)

40 (37.5–43.5)

40 (37–44)

40 (36–44)

40 (36–44)

40 (36–45)

40 (35–46)

40 (35–45)

40 (35–45)

40 (35–45)

40 (35–45)

40 (36–45)

  1. Summary statistics from 1000 simulations. Treatment balance under best case scenario: mean (se): 10 (0), 20 (0), 40 (0) and median (p1 – p99): 10 (10 - 10), 20 (20 – 20), 40 (40 – 40) for sample size 30, 60 and 120 respectively